Aignostics and PanCAN Collaborate on AI Spatial Profiling for Pancreatic Cancer Research

Aignostics has partnered with the Pancreatic Cancer Action Network to expand access to spatial profiling data for pancreatic cancer research, announced in a press release. The collaboration will generate and share AI derived spatial readouts for one of the largest pancreatic cancer datasets assembled to date.

Aignostics will analyze pathology images from PanCAN's SPARK data platform using its Atlas H&E-TME application, which performs tissue quality control, cell classification, and tissue segmentation. The system produces more than 4,500 quantitative readouts per image, powered by Aignostics' pathology foundation model.

The resulting data will be accessible to academic researchers at no cost through SPARK, alongside molecular, clinical, and imaging information from over 1,400 pancreatic cancer patients. Life sciences companies will be able to license the outputs for commercial use. The partnership aims to provide researchers with detailed spatial data to better understand tumor biology and support new therapeutic discoveries.